Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks: Abeona, INKEF, Incyte

November 28, 2018 1:20 AM UTC

Abeona Therapeutics Inc. (NASDAQ:ABEO) terminated Carsten Thiel for personal misconduct towards colleagues, less than eight months after hiring him as CEO. The rare genetic disease company named Head of R&D and CMO João Siffert interim CEO while a permanent successor is sought.

Prior to Abeona, Thiel served as CCO of Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) until his departure in 2017, one of several from that company amid an investigation into Alexion’s sales practices for Soliris eculizumab (see “Alexion Shuffles Management Again”)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article